Tilray Inc (NASDAQ:TLRY – Get Free Report)’s stock price was up 0.3% during trading on Monday . The company traded as high as $1.83 and last traded at $1.80. Approximately 3,599,765 shares changed hands during mid-day trading, a decline of 86% from the average daily volume of 25,842,156 shares. The stock had previously closed at $1.79.
Tilray Price Performance
The company has a current ratio of 2.27, a quick ratio of 1.42 and a debt-to-equity ratio of 0.10. The company has a market capitalization of $1.38 billion, a PE ratio of -4.10 and a beta of 2.19. The stock has a fifty day simple moving average of $1.79 and a 200-day simple moving average of $1.89.
Tilray (NASDAQ:TLRY – Get Free Report) last posted its quarterly earnings results on Monday, July 29th. The company reported ($0.04) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.02) by ($0.02). The firm had revenue of $229.90 million for the quarter, compared to analysts’ expectations of $226.20 million. Tilray had a negative return on equity of 2.63% and a negative net margin of 30.26%. The company’s revenue for the quarter was up 24.8% on a year-over-year basis. During the same period in the prior year, the company earned ($0.15) earnings per share. Equities analysts anticipate that Tilray Inc will post -0.12 earnings per share for the current year.
Institutional Investors Weigh In On Tilray
Tilray Company Profile
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.
Read More
- Five stocks we like better than Tilray
- 3 Grocery Stocks That Are Proving They Are Still Essential
- How to Invest in Silver: A Beginner’s Guide
- What Is WallStreetBets and What Stocks Are They Targeting?
- Monday.com’s Stock Results Will Brighten Any Investor’s Week
- The How and Why of Investing in Gold Stocks
- 3 Must-Watch Stocks After a Bullish Goldman Sachs Recommendation
Receive News & Ratings for Tilray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray and related companies with MarketBeat.com's FREE daily email newsletter.